In the glioma 261 model (GL261), through the analysis of cells that infiltrate the glioma, Qian et al. demonstrated that PD-1 expression is higher both on CD4+ and CD8+ T cells and increases during tumor progression. The gene discussed is CD4; the disease is central nervous system cancer.